Related Experiment Videos
[Polyamine excretion in patients with tumors]
Voprosy Onkologii
|January 1, 1976
Summary
Increased urinary polyamines indicate cancer in stomach, lung, breast, and cervix. Levels normalize after tumor removal or chemotherapy, suggesting polyamine testing for cancer diagnosis and treatment monitoring.
Area of Science:
- Biochemistry
- Oncology
- Urology
Context:
- Elevated polyamine excretion is observed in patients with various cancers, including stomach, lung, mammary gland, and cervical cancers.
- This increase is significantly higher compared to individuals with non-tumorous conditions or healthy controls.
- Polyamines are biologically active amines crucial for cell growth and proliferation.
Purpose:
- To investigate the correlation between polyamine excretion levels and the presence of malignant tumors.
- To evaluate the utility of polyamine determination as a diagnostic marker for cancer.
- To assess the effectiveness of cancer treatments by monitoring polyamine levels.
Summary:
- Urinary polyamine excretion is significantly elevated in patients diagnosed with stomach, lung, mammary gland, and cervical cancers.
- Following successful surgical tumor removal or chemotherapy, polyamine levels in diurnal urine decrease to normal ranges.
- These findings suggest that polyamine excretion patterns can serve as a valuable indicator in cancer diagnosis and treatment efficacy assessment.
Impact:
- The determination of urinary polyamines can potentially serve as a non-invasive laboratory diagnostic test for malignant tumors.
- Monitoring polyamine levels offers a criterion for evaluating the success and efficacy of cancer therapies.
- This research may lead to improved diagnostic tools and personalized treatment strategies in oncology.